Stability and removal of atorvastatin, rosuvastatin and simvastatin from wastewater

References

• Standley LJ, Rudel RA, Swartz CH, et al. Wastewater – contaminated ground water as a source of endogenous hormones and pharmaceuticals to surface water ecosystems. Environ Toxicol Chem. 2008;27(12):2457–2468. doi: 10.1897/07-604.1
   PubMed Web of Science ®Google Scholar
• Purdom CE, Hardiman PA, Bye VJ, Eno NC, Tyler CR, Sumpter JP. Estrogenic effects of effluents from sewage treatment works. Chem Ecol. 1994;8:275–285. doi: 10.1080/02757549408038554
   Google Scholar
• Jobling S, Nolan M, Tyler CR, Brighty G, Sumpter JP. Widespread sexual disruption in wild fish. Environ Sci Technol. 1998;32:2498–2506. doi: 10.1021/es9710870
   Web of Science ®Google Scholar
• Metcalfe CD, Metcalfe TL, Kiparissis Y, et al. Estrogenic potency of chemicals detected in sewage treatment plant effluents as determined by in vivo assays with Japanese medaka (Oryziaslatipes). Environ Toxicol Chem. 2001;20(2):297–308. doi: 10.1897/1551-5028(2001)020<0297:EPOCDI>2.0.CO;2
   PubMed Web of Science ®Google Scholar
• Tabata A, Kashiwada S, Ohnishi Y, et al. Estrogenic influences of estradiol-17, p -nonylphenol and bisphenol-A on Japanese medaka (Oryziaslatipes) at detected environmental concentrations. Water Sci Technol. 2001;43:109–116.
   PubMed Web of Science ®Google Scholar
• Brody JG, Rudel RA. Environmental pollutants and breast cancer. Environ Health Perspect. 2003;111:1007–1019. doi: 10.1289/ehp.6310
   PubMed Web of Science ®Google Scholar
• Buser H-R, Muller MD, Theobald N. Occurrence of the pharmaceutical drug clofibric acid and the herbicide mecoprop in various Swiss lakes and in the North Sea. Environ Sci Technol. 1998;32:188–192. doi: 10.1021/es9705811
   Web of Science ®Google Scholar
• Kolpin DW, Furlong ET, Meyer MT, et al. Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999–2000: a national reconnaissance. Environ Sci Technol. 2002;36:1202–1211. doi: 10.1021/es011055j
   PubMed Web of Science ®Google Scholar
• Glassmeyer ST, Furlong ET, Kolpin DW, et al. Transport of chemical and microbial compounds from known wastewater discharges: potential for use as indicators of human fecal contamination. Environ Sci Technol. 2005;39:5157–5169. doi: 10.1021/es048120k
   PubMed Web of Science ®Google Scholar
• Buerge IJ, Poiger T, Muller MD, Buser H-R. Caffeine, an anthropogenic marker for wastewater contamination of surface waters. Environ Sci Technol. 2003;37:691–700. doi: 10.1021/es020125z
   PubMed Web of Science ®Google Scholar
• Heberer T. Tracking persistent pharmaceutical residues from municipal sewage to drinking water. J Hydrol. 2002;266:175–189. doi: 10.1016/S0022-1694(02)00165-8
   Web of Science ®Google Scholar
• Tixier C, Singer HP, Oeller S, Muller SR. Occurrence and fate of carbamazepine, clofibric acid, diclofenac, ibuprofen, ketoprofen, and naproxen in surface waters. Environ Sci Technol. 2003;37:1061–1068. doi: 10.1021/es025834r
   PubMed Web of Science ®Google Scholar
• Webb S, Ternes T, Gibert M, Olejniczak K. Indirect human exposure to pharmaceuticals via drinking water. Toxicol Lett. 2003;142:157–167. doi: 10.1016/S0378-4274(03)00071-7
   PubMed Web of Science ®Google Scholar
• Gros M, Petrović M, Barceló D. Multi-residue analytical methods using LC-tandem MS for the determination of pharmaceuticals in environmental and wastewater samples: a review. Anal Bioanal Chem. 2006;386:941–952. doi: 10.1007/s00216-006-0586-z
   PubMed Web of Science ®Google Scholar
• Tyler CR, Routledge EJ. Natural and anthropogenic environmental estrogens: the scientific basis for risk assessment. Estrogenic effects in fish in English rivers with evidence of their causation. Pure Appl Chem. 1998;70:1795–1804. doi: 10.1351/pac199870091795
   Web of Science ®Google Scholar
• Johnson AC, Belfroid A, Di Corcia A. Estimating steroid estrogens inputs into activated sludge treatment works and observations on their removal from the effluent. Sci Total Environ. 2000;256:163–173. doi: 10.1016/S0048-9697(00)00481-2
   PubMed Web of Science ®Google Scholar
• Johnson AC, Sumpter JP. Removal of endocrine disrupting chemicals in activated sludge treatment works. Environ Sci Technol. 2002;35:4697–4703. doi: 10.1021/es010171j
   Web of Science ®Google Scholar
• Lee H-B, Peart TE, Lewina Svoboda M, Backus S. Occurrence and fate of rosuvastatin, rosuvastatin lactone, and atorvastatin in Canadian sewage and surface water samples. Chemosphere. 2009;77:1285–1291. doi: 10.1016/j.chemosphere.2009.09.068
   PubMed Web of Science ®Google Scholar
• Ma PTS, Gil G, Sudhof TC, Bilheimer DW, Goldstein JL, Brown MS. Mevinolin, an inhibitor of cholesterol synthesis, induces mRNA for low density lipoprotein receptor in livers of hamsters and rabbits. Proc Natl Acad Sci USA. 1986;83:8370–8374. doi: 10.1073/pnas.83.21.8370
   PubMed Web of Science ®Google Scholar
• Jones P, Kafonek S, Laurora I, Hunninghake D. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study). Am J Cardiol. 1998;81:582–587. doi: 10.1016/S0002-9149(97)00965-X
   PubMed Web of Science ®Google Scholar
• Ternes TA. Occurrence of drugs in German sewage treatment plants and rivers. Water Res. 1998;32:3245–3260. doi: 10.1016/S0043-1354(98)00099-2
   Web of Science ®Google Scholar
• Jemal M, Ouyang Z, Chen BC, Teitz D. Quantitation of the acid and lactone forms of atorvastatin and its biotransformation products in human serum by high-performance liquid chromatography with electrospray tandem mass spectrometry. Rapid Commun Mass Spectrom. 1999;13:1003–1015. doi: 10.1002/(SICI)1097-0231(19990615)13:11<1003::AID-RCM597>3.0.CO;2-L
   PubMed Web of Science ®Google Scholar
• Bullen WW, Miller RA, Hayes RN. Development and validation of a high- performance liquid chromatography–tandem mass spectrometry assay for atorvastatin, ortho-hydroxy atorvastatin, and para-hydroxy atorvastatin in human, dog, and rat plasma. J Am Soc Mass Spectrom. 1999;10:55–66. doi: 10.1016/S1044-0305(98)00118-4
   PubMed Web of Science ®Google Scholar
• Martin PD, Warwick MJ, Dane AL, et al. Metabolism, excretion, and pharmacokinetics of rosuvastatin in healthy adult male volunteers. Clin Ther. 2003;25:2822–2835. doi: 10.1016/S0149-2918(03)80336-3
   PubMed Web of Science ®Google Scholar
• Cermola F, DellaGreca M, Rosaria Iesce M, Montanaro S, Previtera L, Temussi F. Photochemical behavior of the drug Atorvastatin in water. Tetrahedron. 2006;62:7390–7395. doi: 10.1016/j.tet.2006.05.027
   Web of Science ®Google Scholar
• Ridker PM, Danielson ED, Fonseca FAH, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359(21):2195–2207. doi: 10.1056/NEJMoa0807646
   PubMed Web of Science ®Google Scholar
• Hoffman WF, Alberts AW, Anderson PS, Smith RL, Willard AK. The organic chemistry of drug design and drug action. J Med Chem. 1996;29:849–852. doi: 10.1021/jm00155a040
   Web of Science ®Google Scholar
• Vickers S, Duncan CA, Chen IW, Rosegay A, Duggan DE. Metabolic disposition studies on simvastatin, a cholesterol-lowering prodrug. Drug Metab Dispos. 1990;18:138–145.
   PubMed Web of Science ®Google Scholar
• Ottmar KJ, Colosi LM, Smith JA. Development and application of a model to estimate wastewater treatment plant prescription pharmaceutical influent loadings and concentrations. B Environ Contam Tox. 2010;84:507–512. doi: 10.1007/s00128-010-9990-3
   PubMed Web of Science ®Google Scholar
• Khamis M, Karaman R, Qurie M, et al. Performance of micelle-clay filters for removing pollutants and bacteria from tertiary treated wastewater. J. Environ. Sci. Eng. 2012;1:160–168.
   Google Scholar
• Karaman R, Khamis M, Qurie M, et al. Removal of Diclofenac potassium from wastewater using clay-micelle complex. Environ. Technol. 2012;33:1279–1287. doi: 10.1080/09593330.2011.619582
   PubMed Web of Science ®Google Scholar
• American Public Health Association (APHA). Standard methods for the examination of water and wastewater. 19th ed. Washington, DC: APHA; 1995.
   Google Scholar
• American Public Health Association (APHA). Standard methods for the examination of water and wastewater. 21th ed. Washington, DC: APHA; 2005.
   Google Scholar
• Polubesova T, Nir S, Zadaka D, et al. Water purification of organic pollutants by optimized micelle-clay systems. Environ. Sci. Technol. 2005;39:2343–2384. doi: 10.1021/es049251o
   PubMed Web of Science ®Google Scholar
• Polubesova T, Zadaka D, Groisman L, Nir S. Water remediation by micelle-clay system: case study for tetracycline and sulfonamide antibiotics. Water Res. 2006;40:2369–2374. doi: 10.1016/j.watres.2006.04.008
   PubMed Web of Science ®Google Scholar
• Zadaka D, Mishael YG, Polubesova T, Serban C, Nir S. Modified silicates and porous glass as adsorbents for removal of organic pollutants from water and comparison activated carbons. Appl Clay Sci. 2007;36:174–181. doi: 10.1016/j.clay.2006.04.012
   Web of Science ®Google Scholar
• Mishael YG, Undabeyita T, Rytwo G, Papahadjopoulos-Sternberg B, Rubin B, Nir S. Sulfometuron adsorption via alkylammonium cations adsorption as monomers and micelles on montmorillonite. J Agri Food Chem. 2002;50:2856–2863. doi: 10.1021/jf011496m
   PubMed Web of Science ®Google Scholar
• Bendz D, Paxéus NA, Ginn TR, Loge FJ. Occurrence and fate of pharmaceutically active compounds in the environment, a case study. J Hazard Mater. 2005;122:195–204. doi: 10.1016/j.jhazmat.2005.03.012
   PubMed Web of Science ®Google Scholar
• Jones OAH, Voulvoulis N, Lester JN. Human pharmaceuticals in wastewater treatment processes. Crit Rev Environ Sci Technol. 2005;35:401–427. doi: 10.1080/10643380590956966
   Web of Science ®Google Scholar
• Prueksaritanont T, Gorham LMMA, Liu L, et al. In Vitro metabolism of simvastatin in humans [SBT] identification of metabolizing enzymes and effect of the drug on hepatic P450S. J. Pharmacol. Exp. Ther. 1997;25(10):1191–1199.
   Google Scholar
• Robert L, Katelijne E, Matthys G, et al. Pharmacokinetics of atorvastatin and its metabolites after single and multiple dosing in hyper cholesterol aemichaemo dialysis patients. Nephrol. Dial. Transplant. 2003;18(5):967–976. doi: 10.1093/ndt/gfg048
   PubMed Web of Science ®Google Scholar
• Liu DY, Jiang J, Zhou H, Hu P. Quantitative determination of atorvastatin and para-hydroxy atorvastatin in human plasma by LC–MS–MS. J Chromatogr Sci. 2008;46(10):862–866. doi: 10.1093/chromsci/46.10.862
   PubMed Web of Science ®Google Scholar
• Jani AJ, Faeth SH, Gardner D. A sexual endophytes and associated alkaloids alter an bhropod community structure and increase herbivore abundances on a native grass. Ecol Lett. 2010;13:106–117. doi: 10.1111/j.1461-0248.2009.01401.x
   PubMed Web of Science ®Google Scholar
• Istvan ES, Deisenhofer J. Structural mechanism for statin inhibition of HMG-CoA reductase. Science. 2001;292:1160–1164. doi: 10.1126/science.1059344
   PubMed Web of Science ®Google Scholar
• Olsson AG, McTaggart F, Raza A. Rosuvastatin: a highly effective new HMG-CoA reductase inhibitor. Cardiovasc Drug Rev. Winter; 2002;20(4):303–328. doi: 10.1111/j.1527-3466.2002.tb00099.x
   PubMed Web of Science ®Google Scholar
• Dakiky M, Khamis M, Manasra A, Mereb M. Selective adsorption of chromium (VI) in industrial waste water using low cost abundantly available adsorbents. Adv Environ Res. 2002;6:533–540. doi: 10.1016/S1093-0191(01)00079-X
   Google Scholar
• Khalaf S, Al-Rimawi F, Khamis M, et al. Efficiency of advanced wastewater treatment plant system and laboratory-scale micelle-clay filtration for the removal of ibuprofen residues. J Environ Sci Health, Part B. 2013;48:814–821. doi: 10.1080/03601234.2013.781372
   PubMed Web of Science ®Google Scholar